These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 814616)

  • 1. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP; Fernandes B
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
    Tanaka E
    Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of thymus-dependent and bursa-dependent lymphocytes (T and B) in some lymphoproliferative diseases].
    Barabino A; Di Benedetto G; Franceschini R; Indiveri F; Puppo F; Soldà AM
    Boll Soc Ital Biol Sper; 1975 Nov; 51(22):1612-6. PubMed ID: 1084753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-diagnostic importance of surface-markers of human T- and B-lymphocytes].
    Cohnen G
    Dtsch Med Wochenschr; 1974 Nov; 99(45):2302-7. PubMed ID: 4217268
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological deficiency in various disorders of lymphoreticular system].
    Frydecka I
    Pol Tyg Lek; 1977 May; 32(22):851-3. PubMed ID: 407553
    [No Abstract]   [Full Text] [Related]  

  • 10. [T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases].
    Michlmayr G; Huber C; Fink U; Falkensammer M; Huber H
    Schweiz Med Wochenschr; 1974 Jun; 104(23):815-20. PubMed ID: 4546217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunology of non-Hodgkin lymphomas].
    Ricci C; Cascio G; Bellone G; Borio T; Novarini M; Riposio A; Bozzone D
    Minerva Med; 1983 May; 74(20):1145-56. PubMed ID: 6431332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surface markers of human lymphocyte subpopulations, their biological significance and a study of states of immunological deficits and lymphoproliferative disorders].
    Gupta S; Good RA
    Pol Arch Med Wewn; 1977 Feb; 57(2):149-72. PubMed ID: 403513
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of haematological malignancies and their treatment on host defence factors.
    Hersh EV; Gutterman JU; Mavligit GM
    Clin Haematol; 1976 Jun; 5(2):425-48. PubMed ID: 780032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 17. T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review.
    Whiteside TL; Rowlands DT
    Am J Pathol; 1977 Sep; 88(3):754-92. PubMed ID: 329685
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rosette tests in lymphoproliferative diseases].
    Michlmayr G; Pathouli C; Falkensammer M; Huber C; Huber H; Braunsteiner H
    Schweiz Med Wochenschr; 1976 Jun; 106(23):794-9. PubMed ID: 792996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface immunoglobulin in immunoproliferative diseases.
    Teodorescu M; Mayer EP
    Ann Clin Lab Sci; 1978; 8(5):353-65. PubMed ID: 101125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant disease of the lymphoid system in immunological perspective.
    Hansen JA; Good RA
    Hum Pathol; 1974 Sep; 5(5):567-99. PubMed ID: 4137052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.